Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02458898 · ClinicalTrials.gov registry record · NA

Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT02458898: Completed NA study, sponsored by Stanford University.

NCT02458898 is a NA study that has completed, run by Stanford University. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02458898, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

This is a prospective randomized controlled trial investigating the impact of educational bidirectional text message reminders on gluten free diet adherence among adolescents and young adults with celiac disease age 12-24. Participants will complete a series of online questionnaires assessing quality of life, patient activation, celiac symptoms, and self reported dietary adherence at the beginning and end of the study. Participants will also have their blood drawn to measure Tissue Transglutaminase IgA (TTG IgA) antibody and Deamidated Gliadin Peptide IgA (DGP IgA) at the beginning and end of the study. Lab draws can be done locally, and are at no cost to the participant. Patients are randomized to the intervention or control group based on enrollment TTG IgA. Intervention group receives 45 unique text messages over the 3 month study. A gift card is provided for participation in the study.

Interventions

  • BEHAVIORAL Educational Text Message Reminders

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2015-02
Est. Completion 2016-05
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02458898

The ClinicalTrials.gov registry entry for NCT02458898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Educational Text Message Reminders is the first listed.

NCT02458898 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02458898 about?

NCT02458898 is a clinical study titled "Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease". This is a prospective randomized controlled trial investigating the impact of educational bidirectional text message reminders on gluten free diet adherence among adolescents and young adults with celiac disease age 12-24. Participants will complete a series of online questionnaires assessing qualit...

What is the current status of trial NCT02458898?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2015-02. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02458898?

The interventions under investigation include: Educational Text Message Reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT02458898?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.